Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AEHR TEST SYSTEMS Director's Dealing 2023

Jul 19, 2023

32300_dirs_2023-07-19_20aac4f0-e275-414a-9c63-c0151300ccb9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AEHR TEST SYSTEMS (AEHR)
CIK: 0001040470
Period of Report: 2023-07-17

Reporting Person: SPINK KENNETH B. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-07-17 Common Stock M 11511 $2.4000 Acquired 11511 Direct
2023-07-17 Common Stock M 25000 $1.6350 Acquired 36511 Direct
2023-07-17 Common Stock S 36511 $51.3949 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-07-17 Incentive Stock Option (right to buy) $1.6350 M 25000 Disposed 2026-07-16 Common Stock (25000) Direct
2023-07-17 Incentive Stock Option (right to buy) $2.4 M 11511 Disposed 2025-08-17 Common Stock (11511) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 109866 Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.25 to $51.75, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

F2: The amount reported includes shares subject to unvested restricted stock units.

F3: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.